# Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

> **NCT05475847** · PHASE1 · UNKNOWN · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** Autologous Tumor Infiltrating Lymphocytes (C-TIL052A) Injection

## Key facts

- **NCT ID:** NCT05475847
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475847, "Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05475847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*